{"id":43830,"date":"2026-07-23T22:27:00","date_gmt":"2026-07-23T20:27:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=ea3a9047443ea6ebd7e440e761bb6747"},"modified":"2026-07-23T22:27:00","modified_gmt":"2026-07-23T20:27:00","slug":"kaskela-law-llc-announces-investigation-of-amneal-pharmaceuticals-inc-amrx-and-encourages-amrx-shareholders-to-contact-the-firm","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=43830","title":{"rendered":"Kaskela Law LLC Announces Investigation of Amneal Pharmaceuticals, Inc. (AMRX) and Encourages AMRX Shareholders to Contact the Firm"},"content":{"rendered":"<p>PHILADELPHIA--(BUSINESS WIRE)--<a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.kaskelalaw.com%2F&amp;esheet=54576032&amp;newsitemid=20260723118855&amp;lan=en-US&amp;anchor=Kaskela+Law&amp;index=1&amp;md5=82e0dca375577c16e22909a874c38be6\" rel=\"nofollow\" shape=\"rect\">Kaskela Law<\/a> is investigating Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (\u201cAmneal\u201d) on behalf of the company\u2019s current shareholders.<\/p><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260723118855\/en\/780882\/5\/KASKELA_LAW_LOGO_2020.jpg\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260723118855\/en\/780882\/22\/KASKELA_LAW_LOGO_2020.jpg\" \/><\/a><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260723118855\/en\/780882\/5\/KASKELA_LAW_LOGO_2020.jpg\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260723118855\/en\/780882\/21\/KASKELA_LAW_LOGO_2020.jpg\" \/><\/a><p>\nThe investigation seeks to determine whether Amneal or the company\u2019s officers and\/or directors violated the securities laws or breached their fiduciary duties in connection with recent corporate actions.<\/p><p>\n<b><i>Amneal shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) for additional information about this investigation and their legal rights and options at (484) 229 \u2013 0750, or by email at <\/i><\/b><a  href=\"mailto:abell@kaskelalaw.com\" rel=\"nofollow\" shape=\"rect\"><b><i>abell@kaskelalaw.com<\/i><\/b><\/a><b><i>. <\/i><\/b>Investors may contact the firm by clicking on the following link (or if necessary, by copying and pasting the link into your browser) and filling out our online form:<\/p><p>\n<a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fkaskelalaw.com%2Fcase%2Famneal%2F&amp;esheet=54576032&amp;newsitemid=20260723118855&amp;lan=en-US&amp;anchor=https%3A%2F%2Fkaskelalaw.com%2Fcase%2Famneal%2F&amp;index=2&amp;md5=b4f406ff93d54e54a0935731a8eba81f\" rel=\"nofollow\" shape=\"rect\"><b><i>https:\/\/kaskelalaw.com\/case\/amneal\/<\/i><\/b><\/a><\/p><p>\n<b><span class=\"bwuline\">ABOUT KASKELA LAW:<\/span><\/b><\/p><p>\nKaskela Law LLC <i><span class=\"bwuline\">exclusively<\/span><\/i> represents investors in securities fraud, corporate governance, and merger &amp; acquisition litigation on a contingent basis (<i>i.e.<\/i>, the firm\u2019s clients are never responsible for any out-of-pocket costs for legal representation). Since 2020, the firm has helped to recover over $500 million for investors. For additional information about Kaskela Law LLC, including the firm\u2019s recent notable recoveries for investors, please visit <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fkaskelalaw.com%2Ffeatured-cases%2F&amp;esheet=54576032&amp;newsitemid=20260723118855&amp;lan=en-US&amp;anchor=www.kaskelalaw.com&amp;index=3&amp;md5=22ef0d41bd804616dce4b5c61d8a948c\" rel=\"nofollow\" shape=\"rect\">www.kaskelalaw.com<\/a>.<\/p><p>\nThis communication may constitute attorney advertising in certain jurisdictions.<\/p><br\/> <b>Contacts<\/b> <br\/><p>\n<b>KASKELA LAW LLC<\/b><br\/>D. Seamus Kaskela, Esq.\n<br\/>(<a  href=\"mailto:skaskela@kaskelalaw.com\" rel=\"nofollow\" shape=\"rect\">skaskela@kaskelalaw.com<\/a>)\n<br\/>Adrienne Bell, Esq.\n<br\/>(<a  href=\"mailto:abell@kaskelalaw.com\" rel=\"nofollow\" shape=\"rect\">abell@kaskelalaw.com<\/a>)\n<br\/>18 Campus Blvd., Suite 100\n<br\/>Newtown Square, PA 19073\n<br\/>(484) 229 - 0750\n<br\/><a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.kaskelalaw.com%2F&amp;esheet=54576032&amp;newsitemid=20260723118855&amp;lan=en-US&amp;anchor=www.kaskelalaw.com&amp;index=4&amp;md5=6e27d1e6e2fdb5bf24b2dbe676f53dcb\" rel=\"nofollow\" shape=\"rect\">www.kaskelalaw.com<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>PHILADELPHIA&#8211;(BUSINESS WIRE)&#8211;Kaskela Law is investigating Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (\u201cAmneal\u201d) on behalf of the company\u2019s current shareholders.<br \/>\nThe investigation seeks to determine whether Amneal or the company\u2019s officers and\/or dir&#8230;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-43830","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/43830","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=43830"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/43830\/revisions"}],"predecessor-version":[{"id":43831,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/43830\/revisions\/43831"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=43830"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=43830"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=43830"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}